(NASDAQ: PEPG) Pepgen's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.71%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 35.62%.
Pepgen's earnings in 2026 is -$89,655,000.On average, 9 Wall Street analysts forecast PEPG's earnings for 2026 to be -$86,007,069, with the lowest PEPG earnings forecast at -$102,276,809, and the highest PEPG earnings forecast at -$73,296,767. On average, 8 Wall Street analysts forecast PEPG's earnings for 2027 to be -$87,555,252, with the lowest PEPG earnings forecast at -$127,338,014, and the highest PEPG earnings forecast at -$67,491,083.
In 2028, PEPG is forecast to generate -$88,826,973 in earnings, with the lowest earnings forecast at -$123,274,035 and the highest earnings forecast at -$66,765,372.